Announcement

Collapse
No announcement yet.

What's new in MS Research Nov. 2019

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    What's new in MS Research Nov. 2019

    Just came in through my email - https://mymsaa.org/news/whats-new-in...paign=november

    Highlighting:

    *Ofatumumab Favorable Phase III result
    *Mayzent
    *Impact of extending Tysabri® dosing
    *What’s the risk of “rebound” disease activity after stopping Gilenya
    *Assessing Ocrevus® beyond clinical trials
    *FDA approves Vumerity
    *A tilt toward monoclonal antibody therapy as first-line MS treatment
    *Further evidence supporting early initiation of disease-modifying therapy

    And more worth reading!
    1st sx '89 Dx '99 w/RRMS - SP since 2010
    Administrator Message Boards/Moderator

    #2
    Very good info! Thank you Seasha.
    PPMS for 26 years (dx 1998)
    ~ Worrying will not take away tomorrow's troubles ~ But it will take away today's peace. ~

    Comment


      #3
      Thank you Seasha.
      God Bless Us All

      Comment

      Working...
      X